Frontlight ResearchEarly access
Trial site
Fuzhou
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer2 trials
- Chronic spontaneous urticaria1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Gastric and oesophageal cancer1 trial
- Hidradenitis suppurativa1 trial
- Huntington's disease1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Myeloproliferative neoplasms1 trial
- Thyroid cancer1 trial
- Phase
- Phase 39 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals13 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Active, not recruiting
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer2 recruiting
- Huntington's disease1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026